CXCL10 and familial pancreatic carcinoma: CXCL10 and CXCL11 were involved in multiple signaling pathways, such as allograft rejection, antigen processing and presentation, autoimmune thyroid disease, cell adhesion molecules (CAMs), chemokine signaling, cytokine-cytokine receptor interaction, natural killer (NK) cell-mediated cytotoxicity, and Toll-like receptor signaling, suggesting that CXCL10 and CXCL11 are involved in the pancreatic cancer TME and play an important role in immune infiltration.